江苏恒瑞医药简介 PPT

Jinagsu Hengrui Sales Status
Top 5 Products in 2004
Unit:Million RMB 180 160 140 120 100 80 60 40 20 0
Aiheng
Tongao
Lelang
Nuobang
Aisu
FDA Approving
● 2001年恒瑞医药原料药异环磷酰胺、足叶乙甙、美司那、噻 替派通过了美国FDA验证。
•
抗生素
Antibiotics
R & D Activity 研究
植物药 Plant Drugs • • • 肝病治疗药Liver Treatment Drugs 镇咳药 Antitussivers 妇科用药 Gynecological Drugs
生物工程 Biology Engineering • • 单克隆抗体 Monoclonal Antibody 多肽合成
董事长 孙飘扬
公司现有员工2000人，研发人员230人
Main Businesses Line
Hengrui mainly produces antineoplastics, cardiovascular, analgesic, antibiotics . Hengrui was the No. 1 Antineoplastic sales in China Market in 2003、2004.
Pharmaceuticals and R&D
Shanghai Hengrui Medicine & Chengdu Hengrui Medicine
☉ 连云港
成都☉
☉ 上海
Workshop & Equipment Hengrui has two factory zones, the old one is located at Xinpu, the new one is located at ECO. & TECH Development Zone.
R &D Activity 研究与开发
恒瑞拥有2个研究中心 Hengrui Has Two R&D Centers • 恒瑞连云港研究中心 Lianyungang R&D Center 人员Researcher and Engineer：130 Persons 化学合成、植物药、中试研究、通用名药物 Chemical Synthesizing, Plant Drugs, Scale Test Before Production, Generic Medicines • 恒瑞上海研究中心 Shnaghai R&D Center 人员Researcher and Engineer：60 Persons
药物设计、化学合成、制剂研究、生物工程
Drug Design ,Chemical Synthesizing, Preparation Improvement, Biology Engineering
R & D Activity 研究
化学药物 Chemical Medicine: • COX-2抑制剂 Inhibitor BNP909 in Phase I BNP811 in Preclinical • • • 糖尿病PPARγ激动剂 Diabetes PPARγAgonist 抗肿瘤药物 Antineoplastics 胃动力药 Gastrokinetic agents
Polypeptide Synthesis
合作研究 R&D Cooperation
• 与美国Chiron公司合作研究
Cooperation Development with Chiron in USA : Eg5
•
与瑞典Medvir公司研究治疗 Cooperation with Medvir Co., in Sweden of for Development
Ifosfamide, Etoposide, Mesna and Thiotepa were
approved by FDA in 2001.
Export Status Of Raw Chemical Material
Unit: ￥Ten thousand(RMB)
6000 5000 4000 3000 2000 1000 0 2001 2002 2003 2004 2005
Shanghai Hengrui was in production in Jun. 2004
Shanghai Hengrui Campus
Sales Net
恒瑞有九个销售公司，在全国各地有80个办事处， 共有1500名销售代表 Sale network covers all of the country. There are 62 sale offices inside China. Salespersons are over 1300. Active Pharmaceutical ingredients are mainly sold to USA and Europe.,
Freeze Dryer Imported from EDWARDS
Form-Fill-Seal Line
Solid Preparation Auto-Line
Auto-Packing Line
Subsidiary company －－Shanghai Hengrui
● 上海分公司2004年上半年பைடு நூலகம்成投产。
恒瑞现有两个厂区：新浦厂区 开发区新厂区
Workshop & Equipment
The Xinpu factory is the main area of synthesizing and producing bulk drugs, including two solid preparation which passed to GMP inspection and 6 bulk drugs workshops. It can produce 20 kinds of chemical medicines 1.6 billion pills, 50 tons of 40 kinds of bulk drugs per year.
Jiangsu Hengrui Medicine Co., Introduction
Jiangsu Hengrui Medicine Co., Ltd
江苏恒瑞医药股份有限公司
2006
Better medicines to people’s health
关爱人类健康
Jiangsu Hengrui Medicine
The new factory has an area of 30 thousand of square meters, which built preparation workshops according to GMP, and imported a batch of advanced equipment and production line. Now the factory is capable of producing 50 million injections, 2 million lyophilized powders and 2 million sterile split charging powder. 开发区新厂区占地3万多平方米，新建了符合GMP要求 的制剂车间，并已引进了一批国外的先进设备仪器，新增年 产针剂5000万支、冻干粉针200万瓶、灭菌分装粉针200万 瓶的生产能力。
恒瑞主要从事抗肿瘤药、心血管类药、镇痛类药、 抗生素的生产。 2003、2004年抗肿瘤药销量全国排名第一。
Hengrui Group
Jiangsu Hengrui Medicine Co., Ltd.
Pharmaceuticals and R&D
Shanghai Hengrui Medicine Co., Ltd.
新浦厂区主要是固体制剂与原料药生产地，拥有2个通过 GMP认证的固体制剂车间、6个原料车间。 年生产能力为西药20种16亿片，化学原料药40种50吨。
Head office
Workshop & Equipment
GMP固体制剂车间 Solid Preparation
Workshop & Equipment
Established: 1970 Head Office: Lianyungang ,Jiangsu, China President: Mr.Piaoyang Sun Employees : 1800 including: R&D 230 恒瑞医药始建于1970年，公司位于江苏连云港
Capacity of Jiangsu Hengrui
50 million injections, 2 million lyophilized powders
2 million sterile split charging powder.
500 million troches 12 million transfusion bags
COPD Medicine
Thanks !